How AMGEN is Transforming Patient Engagement and Trial Diversity with Dr. Marisa Cruz, Vice President of Global Digital Medicine at AMGEN

Technology can be used to address critical healthcare gaps and improve clinical trial diversity.

In this episode, Dr. Marisa Cruz, Vice President of Global Digital Medicine at AMGEN, shares her insights into AMGEN’s forward-thinking digital health initiatives. From the company’s ambitious goal to reduce cardiovascular incidents to innovations in AI-driven clinical trial diversity, Dr. Cruz discusses how cutting-edge technologies are being integrated to enhance patient outcomes and make healthcare more accessible. She also highlights the company’s initiatives to empower patients directly, allowing them to take a proactive role in their health through digital engagement. Dr. Cruz dives into the future of digital health and patient-centered care, spotlighting how innovation can bridge gaps in accessibility and improve health outcomes globally. This episode was sponsored by Amgen.

Tune in and learn how AI and machine learning are bridging the gaps in healthcare! 

Resources:

Connect with and follow Marisa Cruz on LinkedIn.

Follow Amgen on LinkedIn and visit their website.

Explore Amgen PARC website.

Discover the LATTICE Consortium website.